Skip to main content

Table 4 Adverse events

From: Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations

Complication

Control (n = 46)

rFVII + platelet (n = 25)

pValue

Reoperation for bleeding

1(2.2%)

0

0.648

Delayed sternal closure

0

0

1

Sternal infection

0

0

1

Postoperative arrhythmia

3(6.5%)

2(8%)

0.581

Acute renal failure

2(4.3%)

1(4%)

0.718

Myocardial infarction

0

0

1

Pulmonary embolism

0

0

1

Mesenteric ischemia

0

0

1

Any stroke

1(2.2%)

1(4%)

0.584

Embolic stroke

0

0

1

Permanent paraparesis

1(2.2%)

0

0.648

Over 7 days stay in ICU

5(10.9%)

2(8%)

0.526

30-day/in-hospital death

2(4.3%)

1(4%)

0.718

  1. Values are expressed as number (percent).